News

THG PLC (LSE:THG) has issued its trading statement for the third quarter ended 30 September 2025, recording total revenue of GBP 405.2 million, a 6.3% increase on a continuing currency (CCY) basis. Growth was driven by a 10.0% year-on-year rise in THG Nutrition and …

Bellway PLC (LSE:BWY) has announced its financial results for the year ended 31 July 2025, showing robust growth in revenue, profit, and housing completions.

Beeks Financial Cloud Group PLC (LSE:BKS),an FTSE AIM 100-listed UK company, provides cloud, connectivity, and analytics solutions for financial services. Operating on an IaaS model, it supports institutions in deploying systems and connecting to exchanges, trading platforms, and cloud providers. Its business is divided …

1Spatial (LSE:SPA) continues to attract positive analyst support. Canaccord Genuity assigned a buy rating on 1Spatial with a target price of AUD 1.94, reflecting an 80.95% increase from current levels. Similarly, Panmure Liberum issued a buy rating with a target of AUD 1.54, indicating …

Macro Update:BP forecasted a rise in upstream production for Q3, reversing its earlier outlook for a decline, supported by higher oil and gas output from U.S. onshore fields, though weaker oil trading and lower gas prices weighed on performance. In the UK, wage growth …

Aviva plc (LSE:AV) has received aBuy ratingfrom Day By Day’s analyst, who set atarget price of AUD 15.63 per share, representing a12.58% increasefrom the current market price.

AstraZeneca (LSE:AZN) is a global, research-driven biopharmaceutical company dedicated to the discovery, development, and marketing of innovative prescription medicines across Oncology, Rare Diseases, and BioPharmaceuticals. Headquartered in Cambridge, UK, the company’s therapies improve the lives of patients in more than 125 countries.